London, 20 July 2015: Technavio, the independent tech-focused global research firm, has published a report on the ablation catheters market in the US 2015-2019, which is expected to grow at a CAGR of 12.23% during the forecast period of 2014-2019.
Rise in incidence of cardiovascular diseases is one of the primary drivers of the market. Also, the growing geriatric population, advances in technology, and increased technological innovations propel market growth.
“Robotic-assisted navigation technologies have significantly improved navigation of needles, catheters, and electrode tips to the particular target during the procedure,” says Faisal Ghaus, Vice President of Technavio.
“Many vendors have developed catheters with robotic navigation techniques. For instance, Hansen Medical provides Sensei X Robotic Catheter System that is used with the Artisan family of control catheters.”
Key Market Drivers
- Rise in Incidence of Cardiovascular Diseases
- Growth in Demand for Ablation Catheter Procedures
- Increase in Awareness Programs
- Increase in MI Surgeries/Procedures
Key Market Trends
- Focusing on R&D for Betterment of Products
- Development of Robotic Navigation Technologies
- Increase in Mergers and Acquisitions
Key Market Vendors
- Biosense Webster Inc. (a J&J company)
- Boston Scientific Corp.
- Medtronic plc
- St. Jude Medical Inc.
https://www.technavio.com/%3Cp%3ETo%20define%20the%20market%20circumstanc…
